Company Overview
Snapshot
Founded in June 2023 by Eduard Papirov, Itzhak Fridman, and Sari Prutchi-Sagiv, Latica Med operates with 1–10 employees. The company has raised $200K across one funding round from PipelBiz. Latica Med is preparing to commence a clinical trial to enhance IVF success rates.
Business overview
Latica Med is a medical devices company focused on developing novel, non-invasive, non-drug therapies for gynecology and other diseases to improve women's fertility. The company utilizes its proprietary patented Acoustic Pulse Technology (APT) device, specifically designed for treating gynecological disorders. This compact, cost-effective device is engineered for treatments over a large area, addressing root causes of infertility such as infections, implantation failures, endometrium thickness, and endometriosis, particularly in preparation for IVF processes. Latica Med operates within the Health Tech & Life Sciences sector, specifically targeting Medical Devices and Medical Treatment & Therapeutics.
Strategic signal
Latica Med is poised for a significant advancement in women's health with the upcoming commencement of a clinical trial for its Acoustic Pulse Technology (APT) device. This trial, aimed at enhancing IVF success rates, signals the company's transition from preclinical development to human validation, which could significantly de-risk its technology and attract further investment in the femtech and fertility markets.
Log in to access full profile ›Company Intelligence Q&A
- What is Latica Med's core technology?
- Latica Med utilizes a proprietary patented Acoustic Pulse Technology (APT) device, which is a compact and cost-effective solution designed for treating gynecological disorders over a large treatment area.
- When was Latica Med founded?
- Latica Med was founded in June 2023.
- Who are the founders of Latica Med?
- The founders of Latica Med are Eduard Papirov, Itzhak Fridman, and Sari Prutchi-Sagiv.
- What is the primary focus of Latica Med's therapies?
- Latica Med's therapies are focused on improving women's fertility by addressing root causes of infertility, such as infections, implantation failures, endometrium thickness, and endometriosis, particularly for women undergoing IVF.
- What is the current development stage of Latica Med's product?
- Latica Med's product, Lati-A, is currently in the clinical trial stage, with a clinical trial set to commence soon to enhance IVF success rates.